ESC Premium Access

Vulnerability of carotid atherosclerosis: relationship with plaque location, plaque eccentricity and vessel remodeling patterns. Insight from the the MAGNETIC observational study

Congress Presentation

About the speaker

Doctor Oronzo Catalano

Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Italy)
0 follower

9 more presentations in this session

Plaque burden, but not the severity of carotid stenosis, predicts adverse cardiovascular events in patients at high and very high cardiovascular risk

Speaker: Mr V. Genkel (Chelyabinsk, RU)


Wall shear stress measurement by ultrafast vector flow imaging for atherosclerotic carotid stenosis

Speaker: Mr G. Goudot (Paris, FR)


Gender differences in the prevalence of a normal IMT with increasing severity of carotid disease.

Speaker: Doctor M. Matangi (Kingston, CA)


Endotrophin, a fragment of collagen type VI, is correlated to IMT and associated with cardiovascular events in patients with atherosclerosis and diabetes: the IMI-SUMMIT cohort

Speaker: Doctor S. Holm Nielsen (Kongens Lyngby, DK)


Exploration of biomarkers for subclinical atherosclerosis in an African population using a proteomics chip targeted at inflammation and cardiovascular disease

Speaker: Doctor A. Jujic (Malmo, SE)


Access the full session

New data in carotid disease: From understanding the pathology to management

Speakers: Doctor O. Catalano, Mr V. Genkel, Mr G. Goudot, Doctor M. Matangi, Doctor S. Holm Nielsen...

About the event



31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

27 August 2021

ESC Premium Access

EMPEROR-Preserved - Discussant review.

27 August 2021

ESC Premium Access

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

27 August 2021

ESC 365 is supported by

logo Novo Nordisk